Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients

Anesthesia and Analgesia

Volumn 105, Issue 5, 2007, Pages 1442-1448

  Dagtekin, Oguzhan ^a   Gerbershagen, Hans J ^a   Wagner, Werner ^a   Petzke, Frank ^a   Radbruch, Lukas ^b   Sabatowski, Rainer ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; OPIATE;

ADULT; AGED; ALERTNESS; ARTICLE; ATTENTION; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRIVING ABILITY; FEMALE; HUMAN; LONG TERM CARE; MALE; MOTOR COORDINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR PERFORMANCE; TRAFFIC; VISUAL ORIENTATION;

EID: 37349118996     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000281078.65585.1e     Document Type: Article

References (47)

1. Evans HC, Easthope SE. Transdermal buprenorphine. Drugs 2003;63:1999-2010
2. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage 2005;29:297-326
3. Radbruch L, Vielvoye-Kerkmeer A. Buprenorphine TDS: the clinical development, rationale and result. Int J Clin Pract Suppl 2003;133:15-18
4. Sittl R. Transdermal buprenorphine in the treatment of chronic pain. Expert Rev Neurother 2005;5:315-23
5. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000;19:16-20
6. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591-600
7. Foley K. Opioids and chronic neuropathic pain. N Engl J Med 2003;348:1279-81
8. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83:761-86
9. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage 2000;19:100-8
10. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995;346:667-70
11. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998;15:185-94
12. Hanks GW, O'Neill WM, Simpson P, Wesnes K. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 1995;48:455-60
13. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage 2003;25:38-47
14. Tassain V, Attal N, Fletcher D, Brasseur L, Degieux P, Chauvin M, Bouhassira D. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003;104:389-400
15. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003;26:913-21
16. Gaertner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Sabatowski R. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 2006;50:664-72
17. Byas-Smith MG, Chapman SL, Reed B, Cotsonis G, The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 2005;21:345-52
18. Clemons M, Regnard C, Appleton T. Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 1996;22:451-68
19. Hanks GW. Morphine sans morpheus. Lancet 1995;346:652-3
20. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:69-77
21. Galski T, Williams JB, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage 2000;19:200-8
22. Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel R, Donner B. Opioids and driving ability. Schmerz 1997;11:233-40
23. Bundesanstalt für Straßenwesen. Begutachtungs-Leitlinien zur Kraftfahrereignung. Bergisch Gladbach: Wirtschaftsverlag NW, 2000
24. International Council on Alcohol Drugs and Traffic Safety (ICADTS). Guidelines on experimental studies undertaken to determine a medicinal drug's effect on driving or skills related to driving. Ontario: ICADTS, 1999
25. Herberg K. Untersuchung der Entwicklung der sicherheitsrelevanten Leistungsfähigkeit mit dem Lebensalter. 2nd ed. Cologne: TÜV Kraftfahrt GmbH, Institut für Verkehrssicherheit, 1998
26. Kroj G. Psychologisches gutachten kraftfahreignung. Bonn: Deutscher Psychologenverlag, 1995
27. Kroj G. Perspektiven für Forschung und Begutachtung aus psychologischer Sicht. In: Bundesanstalt für Straßenwesen, ed. Drogen und Verkehrssicherheit. Bergisch Gladbach: Wirtschaftsverlag NW, 1995:78-82
28. Hilgers R, Friedel B, Berghaus G. Áquivalenztestung im Rahmen experimenteller Untersuchungen zur Fahrtüchtigkeit. In: Bundesanstalt für Straßenwesen, ed. Kongreßbericht 1997 der Deutschen Gesellschaft für Verkehrsmedizin e.V. Bergisch Gladbach: Wirtschaftsverlag NW, 1998:130-4
29. Herberg KW. Age-related changes in aspects of performance relevant to safety. Euro J Ger 2000;2:18-26
30. Bundesregierung Deutschland. Verordnung über die Zulassung von Personen zum Straßenverkehr und zur Ánderung straß enverkehrsrechtlicher Vorschriften. Bundesgesetzblatt 1998;2214-62
31. Schuhfried GmbH. Cognitrone-Handbuch. Mödling: Dr. Schuhfried GmbH, 1994
32. Schuhfried GmbH. Wiener Determinationstest, Version 2.00. Mödling: Dr. Schuhfried GmbH, 1996
33. Schuhfried GmbH. Zweihand-Koordination, Version 4.00. Mödling: Dr. Schuhfried GmbH, 1995
34. Schuhfried GmbH. Vigilanz, Version 5.00. Mödling: Dr. Schuhfried GmbH, 1995
35. Thapar P, Zacny JP, Thompson W, Apfelbaum JL. Using alcohol as a standard to assess the degree of impairment induced by sedative and analgesic drugs used in ambulatory surgery. Anesthesiology 1995;82:53-9
36. Richter R, Hobi V. The impairment of the ability to drive with blood alcohol concentrations of 0.5 per mille. A review of the literature. Schweiz Med Wochenschr 1975;105:884-90
37. Bartl G, Lager F, Domesle L. Test performance with minimal alcoholic intoxication. Blutalkohol 1996;33:1-16
38. Herberg KW. Antidepressives and traffic safety. Fortschr Neurol Psychiatr 1994;1:24-8
39. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-87
40. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168-75
41. Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 1997;73:369-75
42. Veldhuijzen DS, van Wijck AJM, Wille F, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, Volkerts ER. Effect of chronic non-malignant pain on highway driving performance. Pain 2006;122:28-35
43. Kuhajda M, Thorn B, Klinger M, Rubin N. The effect of headache pain on attention (encoding) and memory (recognition). Pain 2002;97:213-21
44. Breivik H. Stable long-term opioid medication per se does not always cause loss of driving ability: the doctor and the patient must consider additional risk factors for unsafe driving. Acta Anaesthesiol Scand 2006;50:651-2
45. Nilsen HK, Landrø NI, Jenssen GD, Dale O. Effects of chronic non-malignant pain and short-acting opioid on performance in a driving simulator. Eur J Pain 2006;10:S179
46. Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, Besser M. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med 2004;5:42-9
47. Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005;117:388-95